These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9503543)

  • 1. [Lupus erythematosus: effects of different therapeutic methods on intranuclear characteristics of lymphoid cells].
    Khamaganova IV; Savina MI; Khromova SS; Reshina VM; Aleĭnikova NV
    Ter Arkh; 1997; 69(12):76-8. PubMed ID: 9503543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of the lymphoid cell histones in patients with different forms of lupus erythematosus].
    Khamaganova IV; Savina MI; Khromova SS; Reshina VM; Aleĭnikova NV
    Ter Arkh; 1996; 68(12):82-4. PubMed ID: 9054053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood transfusions in the treatment of lupus erythematosus].
    Korolev IuF
    Vestn Dermatol Venerol; 1967 Oct; 41(10):80-3. PubMed ID: 5620496
    [No Abstract]   [Full Text] [Related]  

  • 5. [Change in the amino acid spectrum of the blood serum in patients with lupus erythematosus under the effect of therapy].
    Pavlova LT
    Vestn Dermatol Venerol; 1970 Jul; 44(7):11-4. PubMed ID: 5511088
    [No Abstract]   [Full Text] [Related]  

  • 6. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultrastructural changes in peripheral blood leukocytes in lupus erythematosus].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1976 Oct; (10):3-6. PubMed ID: 1014814
    [No Abstract]   [Full Text] [Related]  

  • 8. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of a pulsed magnetic field in the treatment of lupus erythematosus].
    Khamaganova IV; Berlin IuV; Volkov VE; Voĭnich ZV; Arutiunova ES
    Ter Arkh; 1995; 67(10):84-7. PubMed ID: 8779120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.
    Tsujimura S; Saito K; Nakayamada S; Nakano K; Tanaka Y
    Arthritis Rheum; 2005 Jun; 52(6):1676-83. PubMed ID: 15934077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dyslipoproteinemias in lupus erythematosus and scleroderma].
    Novikov AI; Dobrotina NA; Pavlova LT; Ezhova GP
    Vestn Dermatol Venerol; 1981 Jul; (7):4-7. PubMed ID: 7293472
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytophotometric study of the change in DNA content in the nuclei of human blood lymphocytes in systemic lupus erythematosus].
    Sakene VE; Itashekas RS
    Tsitologiia; 1984 Oct; 26(10):1212-6. PubMed ID: 6515722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of the neurological indices in the treatment of lupus erythematosus].
    Shaposhnikov OK; Popov AK; Sablina ME
    Vestn Dermatol Venerol; 1979 Apr; (4):3-7. PubMed ID: 433398
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sialic acid, serum glycoproteins and uromucoproteins in lupus erythematosus].
    Kononova AN
    Vestn Dermatol Venerol; 1971; 45(3):18-21. PubMed ID: 5122537
    [No Abstract]   [Full Text] [Related]  

  • 15. Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine.
    TYE MJ; WHITE H; APPEL B; ANSELL HB
    N Engl J Med; 1959 Jan; 260(2):63-6. PubMed ID: 13613503
    [No Abstract]   [Full Text] [Related]  

  • 16. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow studies in lupus erythematosus.
    Lagerholm B; Lodin A
    Acta Derm Venereol; 1966; 46(4):314-6. PubMed ID: 4162565
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of cyclin B1 and cyclin dependent kinase inhibitor p21 in lymphocytes in patients with systemic lupus erythematosus.
    Ho CY; Wong CK; Li EK; Tam LS; Lam CW
    J Rheumatol; 2002 Dec; 29(12):2537-44. PubMed ID: 12465148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.
    Anolik JH; Barnard J; Owen T; Zheng B; Kemshetti S; Looney RJ; Sanz I
    Arthritis Rheum; 2007 Sep; 56(9):3044-56. PubMed ID: 17763423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of the preparation essentiale in the therapy of lupus erythematosus].
    Glavinskaia TA; Novikov AI; Pavlova LT
    Vestn Dermatol Venerol; 1983 May; (5):4-7. PubMed ID: 6880388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.